Remove Arrhythmia Remove Cardiomyopathy Remove Defibrillator
article thumbnail

ECG-only Explainable Deep Learning Algorithm Predicts the Risk for Malignant Ventricular Arrhythmia in Phospholamban Cardiomyopathy

HeartRhythm

Arg14del) variant carriers are at risk of developing malignant ventricular arrhythmias (MVA). Accurate risk stratification allows for timely implantation of intracardiac defibrillators (ICD) and is currently performed using a multimodality prediction model. Phospholamban (PLN) p.(Arg14del)

article thumbnail

DH-482888-005 MULTIMODAL EXPLAINABLE ARTIFICIAL INTELLIGENCE IDENTIFIES PATIENTS WITH NON-ISCHAEMIC CARDIOMYOPATHY AT RISK OF LETHAL VENTRICULAR ARRHYTHMIAS

HeartRhythm

The efficacy of implantable cardioverter-defibrillators (ICD) in patients with a non-ischaemic cardiomyopathy (NICM) is being debated. Deep Learning models enable feature extraction from high-dimensional data, such as cardiac MRI (CMR) and ECG.

article thumbnail

Management of arrhythmogenic right ventricular cardiomyopathy

Heart BMJ

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. channels, Connexin 43 and Wnt signalling, potentially modifying myocardial fibrosis.

article thumbnail

Resuscitated from ventricular fibrillation. Should the cath lab be activated?

Dr. Smith's ECG Blog

He was defibrillated into VT. He then underwent dual sequential defibrillation into asystole. VF should make you think of ischemia, cardiomyopathy (especially scar from old MI), or one many other cardiac but non-ischemic etiologies. This patient was witnessed by bystanders to collapse. They started CPR. sodium bicarbonate.

article thumbnail

Evaluation of patients with implantable cardioverter?defibrillator in a Latin American tertiary center

Journal of Cardiovascular Electrophysiology

Progressive decline across periods in mortality rates among patients with implantable cardioverter-defibrillator (ICD). Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern.

article thumbnail

Ablation of Ventricular Tachycardia in Patients with ischemic cardiomyopathy and without an ICD – For the times they are a-changin´?

HeartRhythm

Most patients with VT and structural heart disease preparing for ablation either have or are about to receive an implantable cardioverter defibrillator (ICD) shortly after the procedure to prevent sudden cardiac death from recurrent ventricular arrhythmias (VA).

article thumbnail

Preventive catheter ablation for ventricular arrhythmias in patients with end‐stage heart failure referred for heart transplantation evaluation: Rationale for and design of the CASTLE‐VT trial

European Journal of Heart Failure

Cardiovascular mortality, driven by sudden cardiac death, is the main reason for dying while waiting for heart transplantation (HTx). Methods CASTLE-VT is a randomized evaluation of prophylactic ablative treatment of arrhythmogenic ventricular scar in patients referred for HTx evaluation and diagnosed with ICM.